-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Initiates Coverage On Connect Biopharma Hldgs with Buy Rating, Announces Price Target of $10

Benzinga·10/31/2025 10:16:27
Listen to the news
BTIG analyst Julian Harrison initiates coverage on Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy rating and announces Price Target of $10.